Giovanna Roncador is one of the scientists who generates the most money in Spain thanks to her inventions. The sale of these antibodies to international companies generates approximately one million euros per year in exploitation rights for the CNIO.

The institution has not shared the benefits with the inventors since 2020 due to a Kafkaesque bureaucratic mess. The researcher estimates that the sale of 65 of her antibodies has produced more than 8.5 million euros of net income in the public coffers of the CN IO since 2004. The biologist is the founder and current president of the European Antibodies Snorer's Association. The association is a trade group of scientists and researchers working on cancer. It was founded in 2000 to help found the new cancer reference center in Spain. The organization is based at the National Cancer Research Center (CNIO) in Madrid. The center began to share profits with its inventors in 2014, but stopped doing so with the money of 2020 and subsequent years. A report from the General Intervention of the State Administration recommended “the immediate suspension of the distribution system”